Canada Gazette, Part I, Volume 150, Number 48: GOVERNMENT NOTICES
November 26, 2016
DEPARTMENT OF THE ENVIRONMENT DEPARTMENT OF HEALTH
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999
Publication of final decision after assessment of a substance — phenol, 5-chloro-2-(2,4-dichlorophenoxy) [triclosan], CAS RN (see footnote 1) 3380-34-5 — specified on the Domestic Substances List (subsection 77(6) of the Canadian Environmental Protection Act, 1999)
Whereas triclosan is a substance on the Domestic Substances List identified under subsection 73(1) of the Canadian Environmental Protection Act, 1999;
Whereas a summary of the screening assessment conducted on the substance pursuant to section 74 of the Act is annexed hereby;
And whereas it is concluded that the substance meets one or more of the criteria set out in section 64 of the Act,
Notice therefore is hereby given that the Minister of the Environment and the Minister of Health (the ministers) propose to recommend to His Excellency the Governor in Council that this substance be added to Schedule 1 to the Act.
Notice is furthermore given that the ministers are releasing a proposed risk management approach document for this substance on the Government of Canada's Chemical Substances website (www.chemicalsubstances.gc.ca) to continue discussions with stakeholders on the manner in which the ministers intend to develop a proposed regulation or instrument respecting preventive or control actions in relation to the substance.
Public comment period on the proposed risk management approach document
Any person may, within 60 days after publication of the proposed risk management approach document, file with the Minister of the Environment written comments on the proposed risk management approach document. More information regarding the proposed risk management approach may be obtained from the Government of Canada's Chemical Substances website (www. chemicalsubstances.gc.ca). All comments must cite the Canada Gazette, Part I, and the date of publication of this notice and be sent to the Executive Director, Program Development and Engagement Division, Environment Canada, Gatineau, Quebec K1A 0H3, 819-938-5212 (fax), or by email to eccc.substances.eccc@canada.ca.
In accordance with section 313 of the Canadian Environmental Protection Act, 1999, any person who provides information in response to this notice may submit with the information a request that it be treated as confidential.
Catherine McKenna
Minister of the Environment
Jane Philpott
Minister of Health
ANNEX
Summary of the assessment of triclosan
An assessment of triclosan has been conducted under the Canadian Environmental Protection Act, 1999 (CEPA) to determine if it poses a risk to Canadians and their environment. Triclosan was also scheduled for re-evaluation under Health Canada's Pest Management Regulatory Agency (PMRA) pesticide re-evaluation program pursuant to the Pest Control Products Act (PCPA). The preliminary assessment that preceded this assessment report included a proposed conclusion for triclosan under both CEPA and the PCPA. As of December 31, 2014, the Canadian registrants voluntarily discontinued the sale of pest control products containing triclosan. Consequently, triclosan is no longer registered in Canada as a pest control product under the PCPA. Hence, this assessment does not include a conclusion under the PCPA for these products.
Triclosan [phenol, 5-chloro-2-(2,4-dichlorophenoxy)] (CAS RN 3380-34-5) is used as a material preservative and as an antimicrobial agent in a wide range of products used by industry and consumers to stop the growth of bacteria, fungi and mildew and to deodorize.
Triclosan does not occur naturally in the environment. The potential sources of exposure to triclosan for Canadians include products used by consumers and that are treated with or contain triclosan (including, but not limited to, cosmetics, non-prescription drugs and natural health products) as well as industrial manufacturing or the formulation of products containing triclosan.
Exposure of the general population to triclosan was characterized using the available Canadian biomonitoring data for triclosan from the Canadian Health Measures Survey (CHMS) Cycle 2 (2009–2011), the Plastic and Personal-Care Product Use in Pregnancy (P4) Study, and the Maternal-Infant Research on Environmental Chemicals (MIREC) and MIREC-Child Development Plus (MIREC-CD Plus) studies. These data encompass exposure to triclosan from all potential sources and routes, and are considered the most accurate estimates of total exposure of the general population in Canada to triclosan. Similar levels were observed in the recent CHMS, Cycle 3 (2012–2013). Exposure estimates for children under the age of three were derived separately using a combination of Canadian biomonitoring data (for infants and children three to five years old) and additional estimates to account for potential exposures via breast milk, household dust and mouthing of triclosan-treated plastic products.
In examination of the toxicological database as a whole, the principal toxicity in rodents and dogs following ingestion of triclosan is mainly in the liver, with the mouse being the most sensitive species. Triclosan exposure also results in modest decreases in serum thyroid hormone thyroxine (T4) levels (but not triiodothyronine [T3] or thyroid-stimulating hormone [TSH]) in rats caused by disruption in the target organ (liver) due to rodent-specific metabolism of triclosan. Critical evaluation of the overall database shows that there are no indications of adverse effects on thyroid function in the animal database, and available human data show no changes in thyroid hormone levels or liver function after long-term exposure to low levels of triclosan. Further, humans have a much greater capacity to adapt to deviations in T4 levels than do rodents. Consequently, the overall database does not support the effects of triclosan on thyroid function as a critical effect for risk characterization in humans.
Considering the current available information on the adverse effects of triclosan, an overall database no-observed-adverse-effect level (NOAEL) of 25 mg/kg bw/day was identified from a 90-day oral toxicity study in mice and was conservatively selected to be protective against a number of effects observed in multiple species at higher doses. This NOAEL was considered protective against potential liver effects, if any, that could occur in humans as well as effects in other organs and systems.
Risk to human health from exposure to triclosan is estimated by comparing estimates of exposure in humans with critical effect levels in health effects studies conducted in laboratory animals in order to derive margins of exposure (MOEs). For the general population, comparison of the estimated mean and upper-bound daily intakes with critical effect levels in mice (based on liver effects) resulted in MOEs between 416 and 5 400. For children under the age of three, comparison of aggregate exposure estimates with the critical effect levels resulted in MOEs greater than 3 300. These MOEs were considered adequate to address uncertainties in the health effects and exposure databases for triclosan.
A review of all available information on the potential for triclosan to induce antimicrobial resistance (AMR) was conducted. Although there is the potential for triclosan-resistant bacteria to exist in laboratory and clinical settings, this has not been documented outside of clinical use (e.g. household settings, toothpaste use). Based on available information, induction of AMR from current levels of triclosan has not been identified as a concern for human health.
Triclosan can be released to the environment as a result of its use in many products used by consumers, or as a result of the industrial manufacture of products containing triclosan. The use in products is considered to be the major contributor to releases of triclosan down the drain. Triclosan released into wastewater reaches wastewater treatment plants (see footnote 2) (WWTP), where it is partly removed from wastewater, depending on the type of treatment. Triclosan is released to aquatic ecosystems as part of WWTP effluents. Some triclosan partitions to sludge during the wastewater treatment process. As a result, triclosan also reaches terrestrial ecosystems by way of biosolids amendment to agricultural land.
Triclosan degrades relatively quickly in the environment through biotic and abiotic processes. However, it is ubiquitous in the environment due to the continual release to surface water through WWTP effluents. Therefore, chronic exposure of organisms to triclosan is expected in aquatic ecosystems, especially when close to effluent sources. Exposure of soil organisms is also likely through land application of biosolids.
Triclosan is highly toxic to a variety of aquatic organisms, such as algae, macrophytes, invertebrates, amphibians and fish. Adverse effects that have been observed include reduction in growth, reproduction and survival, and there is evidence of effects on the endocrine system at environmentally relevant concentrations. Triclosan can also be highly bioconcentrated in fish, and there is evidence of bioaccumulation in algae and aquatic invertebrates. Triclosan is also highly toxic to certain soil organisms.
Based on an extensive review of the available toxicity data, a predicted no-effect concentration of 376 ng/L was derived for the aquatic compartment. This threshold includes consideration of endocrine disruptive effects in fish and amphibians.
Exposure of aquatic organisms was estimated using measured concentrations of triclosan in the receiving surface waters, including at or near WWTP effluent discharge points. Measured concentrations of triclosan in surface waters across Canada indicate that triclosan may cause harmful effects in aquatic ecosystems.
Concentrations of triclosan in soils were estimated based on the measured concentrations of triclosan in biosolids in Canada, and using parameters such as triclosan half-lives in soil and the regulated application rates for biosolids. Risk characterization that considered the high toxicity to certain soil organisms indicated that triclosan is not likely to cause harmful effects, given the low predicted soil concentrations.
The most notable transformation products of triclosan, formed through metabolism and degradation or chlorination, are methyl-triclosan and certain lower chlorinated dioxins. While most of the triclosan-derived dioxins are considered to be transient in the environment and of low toxicity, methyl-triclosan has similar properties to triclosan, such as high toxicity and bioaccumulation potential. Although chronic exposure to methyl-triclosan is likely in the environment, it has been detected at concentrations much lower than those of triclosan.
Triclosan is always present in aquatic ecosystems due to its continuous releases. It is a very potent chemical that can accumulate in organisms and cause adverse effects even at low exposure levels in the environment. Triclosan can transform to methyl-triclosan and to certain lower chlorinated dioxins. Overall, considering the potency of triclosan, its widespread occurrence and the current exposure levels observed in the Canadian environment, it is concluded that potential for harm exists from exposure to triclosan in aquatic ecosystems.
Conclusions under CEPA
Based on the adequacy of the MOEs between estimates of aggregated exposure to triclosan and critical effect levels, it is concluded that triclosan is not entering the environment in a quantity or concentration or under conditions that constitute or may constitute a danger in Canada to human life or health; thus, it does not meet the criteria under paragraph 64(c) of CEPA.
Considering all available lines of evidence presented in this assessment report, there is a risk of harm to organisms, but not to the broader integrity of the environment from triclosan. It is concluded that triclosan meets the criteria under paragraph 64(a) of CEPA as it is entering or may enter the environment in a quantity or concentration or under conditions that have or may have an immediate or long-term harmful effect on the environment or its biological diversity. However, it is concluded that triclosan does not meet the criteria under paragraph 64(b) of CEPA as it is not entering the environment in a quantity or concentration or under conditions that constitute or may constitute a danger to the environment on which life depends.
Therefore, it is concluded that triclosan meets one or more of the criteria set out under section 64 of CEPA.
Even though it is continuously present in the environment, triclosan has been determined not to meet the persistence criteria as set out in the Persistence and Bioaccumulation Regulations of CEPA. Similarly, while triclosan accumulates in organisms to levels that can cause adverse effects, it does not meet the bioaccumulation criteria as set out in the Persistence and Bioaccumulation Regulations of CEPA.
The assessment report and the proposed risk management approach document for this substance are available on the Government of Canada's Chemical Substances website (www.chemicalsubstances.gc.ca).
[48-1-o]
DEPARTMENT OF INDUSTRY
OFFICE OF THE REGISTRAR GENERAL
| Name and position |
Order in Council |
|---|---|
BDO Canada LLP |
2016-971 |
Deloitte LLP |
2016-966 and 2016-967 |
KPMG Enterprise |
2016-970 |
LaRocque, Judith Anne |
2016-974 |
Levine, Mitchell |
2016-973 |
PricewaterhouseCoopers LLP |
2016-972 |
Public Sector Pension Investment Board wholly-owned subsidiaries |
2016-968 and 2016-969 |
Rowe, The Hon. Malcolm H. |
2016-956 |
November 18, 2016
Diane Bélanger
Official Documents Registrar
[48-1-o]
DEPARTMENT OF INDUSTRY
OFFICE OF THE REGISTRAR GENERAL
Senators called
His Excellency the Governor General has been pleased to summon to the Senate of Canada, by letters latent under the Great Seal of Canada bearing date of November 10, 2016:
- — Bernard, Wanda Thomas, C.M., O.N.S., of Dartmouth, in the Province of Nova Scotia, member of the Senate and a Senator for the Province of Nova Scotia;
- — Boniface, Gwen, O.Ont., of Orillia, in the Province of Ontario, member of the Senate and a Senator for the Province of Ontario;
- — Bovey, Patricia, of Winnipeg, in the Province of Manitoba, member of the Senate and a Senator for the Province of Manitoba;
- — Cormier, René, of Caraquet, in the Province of New Brunswick, member of the Senate and a Senator for the Province of New Brunswick;
- — Dean, Tony, O.Ont., of Toronto, in the Province of Ontario, member of the Senate and a Senator for the Province of Ontario;
- — Dupuis, Renée, C.M., of Sainte-Pétronille, in the Province of Quebec, member of the Senate and a Senator for the division of The Laurentides, in the Province of Quebec;
- — Forest, Éric, of Rimouski, in the Province of Quebec, member of the Senate and a Senator for the division of Gulf, in the Province of Quebec;
- — Griffin, Diane, O.P.E.I., of Stratford, in the Province of Prince Edward Island, member of the Senate and a Senator for the Province of Prince Edward Island;
- — Hartling, Nancy, O.N.B., of Riverview, in the Province of New Brunswick, member of the Senate and a Senator for the Province of New Brunswick;
- — Marwah, Sarabjit S., of Toronto, in the Province of Ontario, member of the Senate and a Senator for the Province of Ontario;
- — McPhedran, Marilou, C.M., of Winnipeg, in the Province of Manitoba, member of the Senate and a Senator for the Province of Manitoba;
- — Moncion, Lucie, of North Bay, in the Province of Ontario, member of the Senate and a Senator for the Province of Ontario;
- — Pate, Kim, C.M., of Ottawa, in the Province of Ontario, member of the Senate and a Senator for the Province of Ontario;
- — Wetston, Howard, C.M., Q.C., of Toronto, in the Province of Ontario, member of the Senate and a Senator for the Province of Ontario; and
- — Woo, Yuen Pau, of North Vancouver, in the Province of British Columbia, member of the Senate and a Senator for the Province of British Columbia.
November 18, 2016
Diane Bélanger
Official Documents Registrar
[48-1-o]
DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS
CRIMINAL CODE
Designation as fingerprint examiner
Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following person of the Peterborough Police Service as a fingerprint examiner:
Ryan Donaldson
Ottawa, November 7, 2016
Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch
[48-1-o]
DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS
CRIMINAL CODE
Designation as fingerprint examiner
Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following person of the York Regional Police as a fingerprint examiner:
Craig Fowlow
Ottawa, November 7, 2016
Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch
[48-1-o]
DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS
CRIMINAL CODE
Revocation of designation as fingerprint examiner
Pursuant to subsection 667(5) of the Criminal Code, I hereby revoke the designation of the following person of the Edmonton Police Service as a fingerprint examiner:
Gregory Lecerf
Ottawa, November 7, 2016
Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch
[48-1-o]
DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS
CRIMINAL CODE
Revocation of designation as fingerprint examiner
Pursuant to subsection 667(5) of the Criminal Code, I hereby revoke the designation of the following persons of the Ontario Provincial Police as fingerprint examiners:
- A. J. Emmerson
- Bernard J. Graveline
- Gordon L. Lefebvre
Ottawa, November 7, 2016
Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch
[48-1-o]
DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS
CRIMINAL CODE
Revocation of designation as fingerprint examiner
Pursuant to subsection 667(5) of the Criminal Code, I hereby revoke the designation of the following person of the York Regional Police as a fingerprint examiner:
Steve Ross
Ottawa, November 7, 2016
Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch
[48-1-o]
OFFICE OF THE SUPERINTENDENT OF FINANCIAL INSTITUTIONS
INSURANCE COMPANIES ACT
CCR RE — Order to insure in Canada risks
Notice is hereby given of the issuance, pursuant to subsection 574(1) of the Insurance Companies Act, of an order to insure in Canada risks, effective November 10, 2016, authorizing CCR RE to insure in Canada risks falling within the following classes of insurance: accident and sickness, aircraft, automobile, boiler and machinery, fidelity, legal expense, liability, marine, property, and surety.
November 11, 2016
Jeremy Rudin
Superintendent of Financial Institutions
[48-1-o]
OFFICE OF THE SUPERINTENDENT OF FINANCIAL INSTITUTIONS
INSURANCE COMPANIES ACT
Toronto Police Widows and Orphans Fund — Letters patent of continuance and order to commence and carry on business
Notice is hereby given of the issuance,
- pursuant to subsection 34(2) of the Insurance Companies Act, of letters patent continuing Toronto Police Widows and Orphans Fund as a fraternal benefit society under the Insurance Companies Act, effective November 1, 2016; and
- pursuant to subsection 52(3) of the Insurance Companies Act, of an order authorizing Toronto Police Widows and Orphans Fund to commence and carry on business, and to insure risks falling within the class of life insurance, effective November 1, 2016.
November 2, 2016
Jeremy Rudin
Superintendent of Financial Institutions
[48-1-o]
PRIVY COUNCIL OFFICE
Appointment opportunities
We know that our country is stronger — and our government more effective — when decision-makers reflect Canada's diversity. Moving forward, the Government of Canada will use an appointment process that is transparent and merit-based, strives for gender parity, and ensures that Indigenous Canadians and minority groups are properly represented in positions of leadership. We will continue to search for Canadians who reflect the values that we all embrace: inclusion, honesty, fiscal prudence, and generosity of spirit. Together, we will build a government as diverse as Canada.
The Government of Canada is currently seeking applications from diverse and talented Canadians from across the country who are interested in the following positions.
Current opportunities
The following opportunities for appointments to Governor in Council positions are currently open for applications. Every opportunity is open for a minimum of two weeks from the date of posting on the Governor in Council Appointments website (http://www.appointments-nominations.gc.ca/slctnPrcs.asp?menu=1&lang=eng).
| Position | Organization | Closing date |
|---|---|---|
| Director | Canada Pension Plan Investment Board | |
| Chairperson | Canadian Air Transport Security Authority | December 15, 2016 |
| Chairperson | Destination Canada (Canadian Tourism Commission) | December 1, 2016 |
| Member | Judicial Advisory Committees | |
| Director (Federal Representative) | Montréal Port Authority | |
| Members | National Capital Commission | November 28, 2016 |
| Commissioner of Official Languages for Canada | Office of the Commissioner of Official Languages | December 2, 2016 |
| Director (Federal Representative) | Prince Rupert Port Authority | |
| Director (Federal Representative) | Sept-Îles Port Authority | |
| Director (Federal Representative) | Thunder Bay Port Authority | |
| Director (Federal Representative) | Vancouver Fraser Port Authority | |
| Chairperson | Via Rail Canada Inc. | December 15, 2016 |
Upcoming opportunities
New opportunities that will be posted in the coming weeks.
| Position | Organization |
|---|---|
| President (Chief Executive Officer) | Atomic Energy of Canada Limited |
| Chairperson | Canadian Centre on Substance Abuse |
| Directors | Canadian Centre on Substance Abuse |
| Members | Canadian Institutes of Health Research |
| Chairperson | Canadian International Trade Tribunal |
| Chairperson | Canadian Museum for Human Rights |
| Trustees | Canadian Museum for Human Rights |
| Chairperson | Canadian Museum of History |
| Trustees | Canadian Museum of History |
| Vice-Chairperson | Canadian Museum of History |
| Chairperson | Canadian Museum of Immigration at Pier 21 |
| Trustees | Canadian Museum of Immigration at Pier 21 |
| Chairperson | Canadian Museum of Nature |
| Trustees | Canadian Museum of Nature |
| Permanent Members | Canadian Nuclear Safety Commission |
| Directors | Canadian Race Relations Foundation |
| Citizenship Judges | Citizenship Commission |
| Directors | First Nations Financial Management Board |
| Sergeant-at-Arms | House of Commons |
| Members | National Arts Centre Corporation |
| Chairperson | National Battlefields Commission |
| Commissioner | National Battlefields Commission |
| Full-time Member | National Energy Board |
| Members | National Film Board |
| Chairperson | National Gallery of Canada |
| Trustees | National Gallery of Canada |
| Vice-Chairperson | National Gallery of Canada |
| Trustees | National Museum of Science and Technology |
| Director | Office of the Director of Public Prosecutions |
| Executive Vice-Chairperson and Member | Parole Board of Canada |
| Chairperson | Patented Medicine Prices Review Board |
| Member | Patented Medicine Prices Review Board |
| Chairperson and Member | Standards Council of Canada |
| Member | Telefilm Canada |
Ongoing opportunities
Opportunities posted on an ongoing basis.
| Position | Organization |
|---|---|
| Full-time and Part-time Members | Immigration and Refugee Board |
| Members — All regional divisions (full-time positions and part-time positions) | Parole Board of Canada |
| Full-time and Part-time Members (Appeal Division) | Social Security Tribunal |
| Full-time and Part-time Members (General Division — Employment Insurance Section) | Social Security Tribunal |
| Full-time and Part-time Members (General Division — Income Security Section) | Social Security Tribunal |
| Members | Veterans Review and Appeal Board |
[48-1-o]
BANK OF CANADA
Statement of financial position as at October 31, 2016
| ASSETS | Amount | Total |
|---|---|---|
| Cash and foreign deposits | 12.8 | |
| Loans and receivables | ||
| Securities purchased under resale agreements | 7,001.2 | |
| Advances to members of Payments Canada (see footnote *) | — | |
| Advances to governments | — | |
| Other receivables | 6.0 | |
| 7,007.2 | ||
| Investments | ||
| Treasury bills of Canada | 18,044.7 | |
| Government of Canada bonds | 79,082.0 | |
| Other investments | 410.1 | |
| 97,536.8 | ||
| Property and equipment | 539.1 | |
| Intangible assets | 34.7 | |
| Other assets | 42.6 | |
| Total assets | 105,173.2 | |
| LIABILITIES AND EQUITY | Amount | Total |
|---|---|---|
| Bank notes in circulation | 77,200.7 | |
| Deposits | ||
| Government of Canada | 24,542.6 | |
| Members of Payments Canada (see footnote **) | 500.2 | |
| Other deposits | 1,776.9 | |
| 26,819.7 | ||
| Other liabilities | ||
| Securities sold under repurchase agreements | — | |
| Other liabilities | 649.3 | |
| 649.3 | ||
| 104,669.7 | ||
| Equity | ||
| Share capital | 5.0 | |
| Statutory and special reserves | 125.0 | |
| Available-for-sale reserve | 373.5 | |
| 503.5 | ||
| Total Liabilities and Equity | 105,173.2 | |
I declare that the foregoing return is correct according to the books of the Bank.
Ottawa, November 18, 2016
Carmen Vierula
Chief Financial Officer and Chief Accountant
I declare that the foregoing return is to the best of my knowledge and belief correct, and shows truly and clearly the financial position of the Bank, as required by section 29 of the Bank of Canada Act.
Ottawa, November 18, 2016
Stephen S. Poloz
Governor
[48-1-o]